Corpus ID: 744163

ACG Practice Guideline : Evaluation of Abnormal Liver Chemistries

@inproceedings{Kwo2016ACGPG,
  title={ACG Practice Guideline : Evaluation of Abnormal Liver Chemistries},
  author={Paul Y. Kwo and Faasld Facg and Stanley Martin Cohen and Joseph K Lim},
  year={2016}
}
1 . A formal review and literature search of the world literature on MEDLINE and EMBASE databases dealing with the evaluation of abnormal liver chemistries, studies that dealt with normal or reference range for alanine aminotransferase (ALT) levels and what thresholds trigger an evaluation for actionable liver disease. Studies detailing the relationship between ALT and nonalcoholic fatty liver disease, as well as studies assessing the signifi cance of elevated liver chemistries on overall… Expand
Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression
TLDR
Advances in -omics approach have generated clinically significant biomarker candidates for liver fibrosis that need further evaluation that need to be evaluated. Expand
Screening for impaired liver function as a risk factor for drug safety at hospital admission of surgical patients
TLDR
A significant proportion of patients admitted for surgery have clinically elevated liver parameters and potentially need medication adjustment, and a pharmacist-led screening already at hospital admission can support the identification of patients with clinically relevant elevated liver parameter and patients at risk by calculating liver scores under routine conditions. Expand
Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
TLDR
A new look at the prevalence of non-alcoholic fatty liver disease and the severity of fibrosis among T2DM patients in Vietnam is taken and screening for NAFLD and for evaluating the severityof liver fibrosis in T1DM patients is supported. Expand
Effectiveness of metabolic therapy in patients with acute coronary syndrome (ACS) - myocardial infarction (MI) with disfunctional liver conditions
TLDR
Inclusion in the complex program of patients treatment with acute coronar syndrome (MI) L-arginine and L-carnitine contributes to the restoration of endothelial function of blood vessels, antioxidant protection of the body and increases energy supply of myocarditis. Expand
Antioxidants as recipes for efavirenz-induced liver damage: A study in albino rats
TLDR
This paper aims to provide a history of Pharmacology in Nigeria and its applications in the context of modern medicine and its role in the treatment of infectious disease. Expand

References

SHOWING 1-10 OF 96 REFERENCES
AGA technical review on the evaluation of liver chemistry tests.
TLDR
To provide high-quality, cost-effective health care, a rational approach for the appropriate evaluation of serum liver chemistries is essential for all practicing physicians. Expand
Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests.
TLDR
The international normalized ratio should not be the sole method for reporting results of prothrombin time in liver disease; additional research is needed to determine the reporting mechanism that best correlates with functional impairment. Expand
A practice guideline on Wilson disease
TLDR
These guidelines provide data-supported approaches to the diagnosis and management of patients with Wilson disease that are based on broad-based review of the published literature in pediatrics and medicine and 40 accumulated years of personal experience of the authors. Expand
Prevalence of Abnormal Liver Function Tests in Celiac Disease and the Effect of a Gluten-Free Diet in the US Population
TLDR
Forty percent of individuals will have elevated LFTs at CD diagnosis; however, the majority will normalize with standard CD therapy and should be checked in all patients with CD and coexisting liver disorder should be considered in patients whoseLFTs have not improved within a year on a GFD. Expand
The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
TLDR
This is a practice guideline for clinicians rather than a review article and interested readers can refer to several comprehensive reviews published recently. Expand
Introduction to the Revised American Association for the Study of Liver Diseases Position Paper on Acute Liver Failure 2011
TLDR
Fulminant Wilson's disease can be diagnosed most effectively not by waiting for copper levels (too slow to obtain) or by obtaining ceruloplasmin levels (low in half of all ALF patients, regardless of etiology), but by simply looking for the more readily available bilirubin level and alkaline phosphatase (ALP; very low). Expand
Evaluation of abnormal liver-enzyme results in asymptomatic patients.
Now that routine laboratory testing is automated and is frequently part of an annual checkup, physicians are often faced with the problem of a patient with one abnormal result on measurement of serumExpand
AGA technical review on nonalcoholic fatty liver disease.
TLDR
In this review, the existing literature regarding the nomenclature, clinical and histologic spectrum, natural history, diagnosis, and management of nonalcoholic fatty liver disease are discussed. Expand
Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring
TLDR
Although ALT is useful for detecting acute and chronic hepatic injury, it is not related to severity of acute Hepatitis B and C and only weakly related to severe severity of chronic hepatics injury. Expand
ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
TLDR
This ACG Clinical Guideline is presented an evidence-based approach to diagnosis and management of DILI with special emphasis on DILi due to herbal and dietary supplements and DilI occurring in individuals with underlying liver disease. Expand
...
1
2
3
4
5
...